2022 GLOBAL FINALIST

AarogyaAI

Biotech Female Founder

AarogyaAI aims to diagnose drug-resistant tuberculosis (DR-TB) using Artificial Intelligence, which enables quick and accurate diagnosis of DR-TB in just a few hours. With quick diagnoses, patients can be prescribed drug combinations for instant and effective treatment.

💸 Select investors: India Edison Accelerator, Illumina Accelerator, Entrepreneur First, GEHC, BIRAC

📌 HQ: New Delhi, India

🔗 https://aarogya.ai/

🔗 Crunchbase